Olema Pharmaceuticals OLMA
NASDAQ OLMA
$8.23 -0.04 (-0.48%)
At close: Oct 2, 2026 · 4:00 PM EDT

Olema Pharmaceuticals (OLMA) Return on Equity [ROE] (2020 - 2026)

Updated

Olema Pharmaceuticals' Return on Equity [ROE] was -44.82% in Q2 2026, down 5.76 percentage points from -39.07% a year earlier and down 6.17 percentage points from the prior quarter.

Analysis

Olema Pharmaceuticals (OLMA) Return on Equity [ROE] (2020 - 2026) Analysis & Trends

For FY2025, Return on Equity [ROE] at Olema Pharmaceuticals came in at -36.61%, up 2.48 percentage points from FY2024.

  • Return on Equity [ROE] has now increased for three consecutive years, though with a five-year change of -23.11 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Equity [ROE] was -39.10% in FY2024 (+3.72 pp), -42.81% in FY2023 (+0.65 pp), -43.46% in FY2022 (-20.64 pp) and -22.82% in FY2021 (-9.31 pp).
  • Quarterly Return on Equity [ROE] has moved between -59.07% (Q1 2023) and -19.36% (Q3 2021) over five years.
  • Compared with a year earlier, Return on Equity [ROE] was higher in four of the last eight quarters, with an average year-over-year change of -0.30 percentage points.
  • The best year-over-year quarter for Return on Equity [ROE] over five years was Q1 2024 (a gain of 18.54 percentage points); the worst was Q1 2023 (a drop of 30.42 percentage points).
  • Per Business Quant data, OLMA's Return on Equity [ROE] in the three quarters before Q2 2026 was -38.65% (Q1 2026), -41.34% (Q4 2025) and -45.92% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 Olema Pharmaceuticals 719.73 Mn 719.73 Mn - -44.82%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -44.82%
Mar 31, 2026 -38.65%
Dec 31, 2025 -41.34%
Sep 30, 2025 -45.92%
Jun 30, 2025 -39.07%
Mar 31, 2025 -32.54%
Dec 31, 2024 -42.63%
Sep 30, 2024 -57.72%
Jun 30, 2024 -47.34%
Mar 31, 2024 -40.52%
Dec 31, 2023 -36.53%
Sep 30, 2023 -43.97%
Jun 30, 2023 -57.76%
Mar 31, 2023 -59.07%
Dec 31, 2022 -50.46%
Sep 30, 2022 -44.13%
Jun 30, 2022 -37.98%
Mar 31, 2022 -28.65%
Dec 31, 2021 -24.27%
Sep 30, 2021 -19.36%
API Access

Olema Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=OLMA&period=max&api_key=YOUR_API_KEY